Keyphrases
Alzheimer's Disease
100%
Positron Emission Tomography
100%
Perfusion
100%
Pittsburgh Compound B
100%
Neuronal Injury
100%
Fluorodeoxyglucose
28%
B-image
28%
Disease Progression
14%
Dominantly Inherited Alzheimer Network
14%
Mutation Carriers
14%
Metabolism
14%
Family History
14%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
14%
Radiation Exposure
14%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
14%
Dementia Severity
14%
Sectional Analysis
14%
Longitudinal Analysis
14%
Imaging Biomarkers
14%
Delivery Rate
14%
Brain Perfusion
14%
Voxel-wise
14%
Dynamic Positron Emission Tomography
14%
Perfusion Image
14%
Hypometabolism
14%
Estimation Time
14%
Spatially Correlated
14%
R1 Value
14%
Medicine and Dentistry
Positron Emission Tomography
100%
Alzheimer's Disease
100%
Pittsburgh Compound B
100%
Fluorodeoxyglucose
42%
Biological Marker
14%
Disease Exacerbation
14%
Fluorodeoxyglucose F 18
14%
Radiation Exposure
14%
Family History
14%
Carbon 11
14%
Brain Perfusion
14%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Pittsburgh Compound B
100%
Fluorodeoxyglucose
42%
Biological Marker
14%
Disease Exacerbation
14%
Carbon 11
14%
Fluorodeoxyglucose F 18
14%
Radiation Exposure
14%
Neuroscience
Alzheimer's Disease
100%
Positron Emission Tomography
100%
Metabolic Pathway
25%
Fluorine-18
25%
Immunology and Microbiology
Positron Emission Tomography
100%
Perfusion
100%
Brain Perfusion
25%